Mid-tier IT company Mastek Limited on Friday, September 5, said its wholly-owned subsidiary Mastek (UK) Limited has been named as a supplier on the Digital Technical Clinical Support (DTCS) framework agreement by NHS London Procurement Partnership (LPP).
Through this framework, Mastek will support the NHS and public healthcare bodies in delivering safe, efficient, and modern care via digital clinical services.
The DTCS framework is a strategic initiative of NHS LPP aimed at enabling trusted access to clinical digital support services for NHS organisations and public healthcare providers across the UK. It has been structured to provide greater flexibility, encourage participation from small and medium enterprises, and expand the scope of services offered.
Also Read: Mastek shares surge 13% as Midcap IT stocks rebound; check its highest price target
The framework covers areas such as clinical system architecture, development, integration, implementation, and digital consultancy. By being selected as a supplier, Mastek will play a role in facilitating digital transformation within the UK healthcare sector.
The four-year framework replaces the former Clinical Digital Professional Services (CDPS) agreement and is intended to accelerate the procurement of high-quality clinical digital solutions and infrastructure.
It will encompass the full suite of clinical digital professional services, including services related to both proprietary and open-source solutions. All standalone, clinically-focused digital services are included, enabling healthcare bodies to access the expertise needed to drive modern digital transformation.
Also Read: Mastek shares jump 12% despite weak Q1 — Key factors behind the move
Under the Lot 1 agreement, Mastek will deliver services across cloud hosting, environment build, and ongoing operations and maintenance, to support scalable, secure, and integrated clinical platforms.
Abhishek Singh, President UKI & Europe, Mastek, said, “Mastek securing a place on the DTCS framework reinforces our continued focus on supporting the UK public sector and healthcare ecosystem.”
He added, “With a strong track record of delivering mission-critical digital services across NHS trusts, integrated care systems (ICSs), and arm’s length bodies, we help NHS organisations modernise legacy systems, adopt cloud-native architectures, and build secure, patient-centric digital environments.”
Also Read: Mastek Q1 Results: Profit jumps 29% on-year, revenue grows 12.5%
Shares of Mastek Ltd ended at ₹2,448.50, down by ₹41or 1.65%, on the BSE today, September 5.
